Readers hoping to buy ResMed Inc. (NYSE:RMD) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually set to be one business ...
ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback